Binnopharm production facilities acquired the status of industrial complex

This will allow the company to receive tax preferences and other benefits, including reduced rates of profit tax, preferential rate of land lease and others.

For the city, it is fundamentally important to support high-tech companies and build a comfortable environment for the development of innovative economy, said Natalia Sergunina, Deputy Mayor of Moscow for Economic Policy and Property and Land Relations.

Joint Stock Company Binnopharm is one of the largest Russian full-cycle pharmaceutical companies. The company has its own R&D unit and a production site. It has more than 330 employees, and the manufacturing complex is located in Zelenograd on the area of 32 thousand square meters. In 2016, the output was more than 5.3 million packages of pharmaceuticals, and the investments amounted to 305 million rubles.

JSC Binnopharm plans to reinvest the additional funds obtained as a result of its new status in upgrading production facilities and improving the quality of medicines. In Vodny Stadion technopark, the released funds are scheduled to be spent on upgrading the lighting, air conditioning, fire extinguishing, and video surveillance systems, as well as on reconstruction of access roads.